237 related articles for article (PubMed ID: 31724704)
1. Harnessing targeted DNA methylation and demethylation using dCas9.
Pflueger C; Swain T; Lister R
Essays Biochem; 2019 Dec; 63(6):813-825. PubMed ID: 31724704
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
Tadić V; Josipović G; Zoldoš V; Vojta A
Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
[TBL] [Abstract][Full Text] [Related]
3. Genomic Targeting of TET Activity for Targeted Demethylation Using CRISPR/Cas9.
Nguyen TV; Lister R
Methods Mol Biol; 2021; 2272():181-194. PubMed ID: 34009614
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
[TBL] [Abstract][Full Text] [Related]
5. DNA Methylation Editing by CRISPR-guided Excision of 5-Methylcytosine.
Devesa-Guerra I; Morales-Ruiz T; Pérez-Roldán J; Parrilla-Doblas JT; Dorado-León M; García-Ortiz MV; Ariza RR; Roldán-Arjona T
J Mol Biol; 2020 Mar; 432(7):2204-2216. PubMed ID: 32087201
[TBL] [Abstract][Full Text] [Related]
6. Programmable targeted epigenetic editing using CRISPR system in Bombyx mori.
Liu Y; Ma S; Chang J; Zhang T; Chen X; Liang Y; Xia Q
Insect Biochem Mol Biol; 2019 Jul; 110():105-111. PubMed ID: 31022512
[TBL] [Abstract][Full Text] [Related]
7. Recent trends in CRISPR-Cas system: genome, epigenome, and transcriptome editing and CRISPR delivery systems.
Bae T; Hur JW; Kim D; Hur JK
Genes Genomics; 2019 Aug; 41(8):871-877. PubMed ID: 31119685
[TBL] [Abstract][Full Text] [Related]
8. Advances of epigenetic editing.
Gjaltema RAF; Rots MG
Curr Opin Chem Biol; 2020 Aug; 57():75-81. PubMed ID: 32619853
[TBL] [Abstract][Full Text] [Related]
9. Transgenerationally Transmitted DNA Demethylation of a Spontaneous Epialleles Using CRISPR/dCas9-TET1cd Targeted Epigenetic Editing in Arabidopsis.
Wang M; He L; Chen B; Wang Y; Wang L; Zhou W; Zhang T; Cao L; Zhang P; Xie L; Zhang Q
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142407
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-mediated modification of DNA methylation pattern in the new era of cancer therapy.
Maroufi F; Maali A; Abdollahpour-Alitappeh M; Ahmadi MH; Azad M
Epigenomics; 2020 Oct; 12(20):1845-1859. PubMed ID: 33185489
[TBL] [Abstract][Full Text] [Related]
11. A modular dCas9-SunTag DNMT3A epigenome editing system overcomes pervasive off-target activity of direct fusion dCas9-DNMT3A constructs.
Pflueger C; Tan D; Swain T; Nguyen T; Pflueger J; Nefzger C; Polo JM; Ford E; Lister R
Genome Res; 2018 Aug; 28(8):1193-1206. PubMed ID: 29907613
[TBL] [Abstract][Full Text] [Related]
12. Editing the Epigenome to Tackle Brain Disorders.
Liu XS; Jaenisch R
Trends Neurosci; 2019 Dec; 42(12):861-870. PubMed ID: 31706628
[TBL] [Abstract][Full Text] [Related]
13. Editing of DNA Methylation Patterns Using CRISPR-Based Tools.
Smith J; Banerjee R; Weeks RJ; Chatterjee A
Methods Mol Biol; 2022; 2458():63-74. PubMed ID: 35103962
[TBL] [Abstract][Full Text] [Related]
14. Editing of DNA Methylation Using dCas9-Peptide Repeat and scFv-TET1 Catalytic Domain Fusions.
Morita S; Horii T; Hatada I
Methods Mol Biol; 2018; 1767():419-428. PubMed ID: 29524149
[TBL] [Abstract][Full Text] [Related]
15. The final cut: Cas9 editing.
Taylor DW
Nat Struct Mol Biol; 2019 Aug; 26(8):669-670. PubMed ID: 31285603
[No Abstract] [Full Text] [Related]
16. Regulation of Gene Expression and the Elucidative Role of CRISPR-Based Epigenetic Modifiers and CRISPR-Induced Chromosome Conformational Changes.
Martella A; Fisher DI
CRISPR J; 2021 Feb; 4(1):43-57. PubMed ID: 33616442
[TBL] [Abstract][Full Text] [Related]
17. Targeted DNA demethylation of the Fgf21 promoter by CRISPR/dCas9-mediated epigenome editing.
Hanzawa N; Hashimoto K; Yuan X; Kawahori K; Tsujimoto K; Hamaguchi M; Tanaka T; Nagaoka Y; Nishina H; Morita S; Hatada I; Yamada T; Ogawa Y
Sci Rep; 2020 Mar; 10(1):5181. PubMed ID: 32198422
[TBL] [Abstract][Full Text] [Related]
18.
Liang F; Dong Z; Ye J; Hu W; Bhandari RK; Mai K; Wang X
Epigenetics; 2023 Dec; 18(1):2192326. PubMed ID: 36945831
[TBL] [Abstract][Full Text] [Related]
19. A CRISPR-Cas9-Based Near-Infrared Upconversion-Activated DNA Methylation Editing System.
Chi J; Zhao J; Wei S; Li Y; Zhi J; Wang H; Hou X; Hu L; Zheng X; Gao M
ACS Appl Mater Interfaces; 2021 Feb; 13(5):6043-6052. PubMed ID: 33525876
[TBL] [Abstract][Full Text] [Related]
20. In vivo epigenome editing and transcriptional modulation using CRISPR technology.
Lau CH; Suh Y
Transgenic Res; 2018 Dec; 27(6):489-509. PubMed ID: 30284145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
